ArticleRetrovirology2011

HIV-1 predisposed to acquiring resistance to maraviroc (MVC) and other CCR5 antagonists in vitro has an inherent, low-level ability to utilize MVC-bound CCR5 for entry.

Michael Roche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.